ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 261 filers reported holding ALKERMES PLC in Q1 2017. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $56,000 | +19.1% | 1,000 | 0.0% | 0.00% | -20.0% |
| Q3 2016 | $47,000 | +9.3% | 1,000 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $43,000 | +26.5% | 1,000 | 0.0% | 0.01% | +25.0% |
| Q1 2016 | $34,000 | -57.0% | 1,000 | 0.0% | 0.00% | -55.6% |
| Q4 2015 | $79,000 | +33.9% | 1,000 | 0.0% | 0.01% | +12.5% |
| Q3 2015 | $59,000 | -7.8% | 1,000 | 0.0% | 0.01% | 0.0% |
| Q2 2015 | $64,000 | +4.9% | 1,000 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $61,000 | +3.4% | 1,000 | 0.0% | 0.01% | -11.1% |
| Q4 2014 | $59,000 | +37.2% | 1,000 | 0.0% | 0.01% | +28.6% |
| Q3 2014 | $43,000 | -14.0% | 1,000 | 0.0% | 0.01% | -12.5% |
| Q2 2014 | $50,000 | +13.6% | 1,000 | 0.0% | 0.01% | 0.0% |
| Q1 2014 | $44,000 | +7.3% | 1,000 | 0.0% | 0.01% | 0.0% |
| Q4 2013 | $41,000 | +20.6% | 1,000 | 0.0% | 0.01% | 0.0% |
| Q3 2013 | $34,000 | +17.2% | 1,000 | 0.0% | 0.01% | -11.1% |
| Q2 2013 | $29,000 | – | 1,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 14,040,000 | $313,513,000 | 35.43% |
| Krensavage Asset Management, LLC | 1,411,682 | $31,523,000 | 10.04% |
| Prosight Management, LP | 502,150 | $11,213,000 | 6.01% |
| Hardman Johnston Global Advisors LLC | 5,734,259 | $128,046,000 | 5.76% |
| 13D Management LLC | 415,055 | $9,268,000 | 4.85% |
| Ally Bridge Group (NY) LLC | 300,000 | $6,699,000 | 4.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 593,000 | $13,248,000 | 4.25% |
| GREAT POINT PARTNERS LLC | 507,500 | $11,332,000 | 2.73% |
| Tamarack Advisers, LP | 200,000 | $4,466,000 | 2.62% |
| Zebra Capital Management LLC | 22,134 | $494,000 | 1.88% |